The ischemic preconditioning paradox in deceased donor liver transplantation - Evidence from a prospective randomized single blind clinical trial

American Journal of Transplantation

Volumn 7, Issue 12, 2007, Pages 2788-2796

  Koneru, B ^a   Shareef, A ^a   Dikdan, G ^a   Desai, K ^a   Klein, K M ^a   Peng, B ^a   Wachsberg, R H ^a   De La Torre, A N ^a   Debroy, M ^a   Fisher, A ^a   Wilson, D J ^a   Samanta, A K ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Deceased donor; Ischemia reperfusion injury; Ischemic preconditioning; Liver transplantation

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; INTERLEUKIN 10; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CADAVER DONOR; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FOLLOW UP; GRAFT RECIPIENT; GRAFT SURVIVAL; HISTOPATHOLOGY; HOSPITALIZATION; HUMAN; ISCHEMIC PRECONDITIONING; LENGTH OF STAY; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTHROMBIN TIME; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; THERAPY EFFECT;

ADULT; BIOPSY; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; INTERLEUKIN-10; INTERLEUKIN-6; ISCHEMIC PRECONDITIONING; LIVER; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; REPERFUSION INJURY; SINGLE-BLIND METHOD; TIME FACTORS; TISSUE DONORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 35748953090     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2007.02009.x     Document Type: Article

References (34)

1. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation 1986 74 : 1124 1136.
2. Lee HT, Emala CW. Protective effects of renal ischemic preconditioning and adenosine pretreatment: Role of A(1) and A(3) receptors. Am J Physiol Renal Physiol 2000 278 : F380 F387.
3. Peralta C, Closa D, Xaus C, Gelpi E, Rosello-Catafau J, Hotter G. Hepatic preconditioning in rats is defined by a balance of adenosine and xanthine. Hepatology 1998 28 : 768 773.
4. Lloris-Carsi JM, Cejalvo D, Toledo-Pereyra LH, Calvo MA, Suzuki S. Preconditioning: Effect upon lesion modulation in warm liver ischemia. Transplant Proc 1993 25 : 3303 3304.
5. Clavien PA, Selzner M, Rüdiger HA et al. A prospective randomized study in 100 consecutive patients undergoing major liver resection with versus without ischemic preconditioning. Ann Surg 2003 238 : 843 850 discussion 851-852.
6. Du ZY, Hicks M, Winlaw D, Spratt P, MacDonald P. Ischemic preconditioning enhances donor lung preservation in the rat. J Heart Lung Transplant 1996 15 : 1258 1267.
7. Hotter G, Closa D, Prados M et al. Intestinal preconditioning is mediated by a transient increase in nitric oxide. Biochem Biophys Res Commun 1996 222 : 27 32.
8. Bolli R. Cardioprotective function of inducible nitric oxide synthase and role of nitric oxide in myocardial ischemia and preconditioning: An overview of a decade of research. J Mol Cell Cardiol 2001 33 : 1897 1918.
9. Arai M, Thurman RG, Lemasters JJ. Ischemic preconditioning of rat livers against cold storage-reperfusion injury: Role of nonparenchymal cells and the phenomenon of heterologous preconditioning. Liver Transpl 2001 7 : 292 299.
10. Yin DP, Sankary HN, Chong AS et al. Protective effect of ischemic preconditioning on liver preservation-reperfusion injury in rats. Transplantation 1998 66 : 152 157.
11. Ricciardi R, Shah SA, Wheeler SM et al. Regulation of unflappable in hepatic ischemic preconditioning. J Am Coll Surg 2002 195 : 319 326.
12. Matsumoto T, O'Malley K, Efron PA et al. Interleukin-6 and STAT3 protect the liver from hepatic ischemia and reperfusion injury during ischemic preconditioning. Surgery 2006 140 : 793 802.
13. Arai M, Thurman RG, Lemasters JJ. Contribution of adenosine A(2) receptors and cyclic adenosine monophosphate to protective ischemic preconditioning of sinusoidal endothelial cells against storage/reperfusion injury in rat livers. Hepatology 2000 32 : 297 302.
14. Iniguez M, Berasain C, Martinez-Anso E et al. Cardiotrophin-1 defends the liver against ischemia-reperfusion injury and mediates the protective effect of ischemic preconditioning. J Exp Med 2006 203 : 2809 2815.
15. Chouker A, Martignoni A, Schauer R et al. Beneficial effects of ischemic preconditioning in patients undergoing hepatectomy: The role of neutrophils. Arch Surg 2005 140 : 129 136.
16. Li SQ, Liang LJ, Huang JF, Li Z. Ischemic preconditioning protects liver from hepatectomy under hepatic inflow occlusion for hepatocellular carcinoma patients with cirrhosis. World J Gastroenterol 2004 10 : 2580 2584.
17. Koneru B, Fisher A, He Y et al. Ischemic preconditioning in deceased donor liver transplantation: A prospective randomized clinical trial of safety and efficacy. Liver Transpl 2005 11 : 196 202.
18. Azoulay D, Del Gaudio M, Andreani P et al. Effects of 10 minutes of ischemic preconditioning of the cadaveric liver on the graft's preservation and function: The ying and the yang. Ann Surg 2005 242 : 133 139.
19. Cescon M, Grazi GL, Grassi A et al. Effect of ischemic preconditioning in whole liver transplantation from deceased donors. A pilot study. Liver Transpl 2006 12 : 628 635.
20. Feng S, Goodrich NP, Bragg-Gresham JL et al. Characteristics associated with liver graft failure: The concept of a donor risk index. Am J Transplant 2006 6 : 783 790.
21. Busquets J, Figueras J, Serrano T et al. Post reperfusion biopsies are useful in predicting complications after liver transplantation. Liver Transpl 2001 7 : 432 435.
22. Banff schema for grading liver allograft rejection: An international consensus document. Hepatology 1997 25 : 658 663.
23. Glanemann M, Strenziok R, Kuntze R et al. Ischemic preconditioning and methylprednisolone both equally reduce hepatic ischemia/reperfusion injury. Surgery 2004 135 : 203 214.
24. Adam R, Arnault I, Bao YM, Salvucci M, Sebagh M, Bismuth H. The effect of Ischemic preconditioning on hepatic tolerance to cold ischemia in the rat. Transplant Int 1998 11 (Suppl.1 S168 S170.
25. Amador MA, Marti J, Rodriguez-Laiz G et al. Ischemic preconditioning during donor procurement in orthotopic liver transplantation. Preliminary results of a prospective and randomized trial. J Hepatol 2004 40 (Suppl. 1 37.
26. Serafin A, Rosello-Catafau J, Prats N, Gelpi E, Rodes J, Peralta C. Ischemic preconditioning affects interleukin release in fatty livers of rats undergoing ischemia/reperfusion. Hepatology 2004 39 : 688 698.
27. Peralta C, Fernandez L, Panes J et al. Preconditioning protects against systemic disorders associated with hepatic ischemia-reperfusion through blockade of tumor necrosis factor-induced P-selectin up-regulation in the rat. Hepatology 2001 33 : 100 113.
28. Tacchini L, Cairo G, De Ponti C, Massip M, Rosello-Catafau J, Peralta C. Up regulation of IL-6 by ischemic preconditioning in normal and fatty rat livers: Association with reduction of oxidative stress. Free Radic Res 2006 40 : 1206 1217.
29. Serafin A, Rosello-Catafau J, Prats N, Xaus C, Gelpi E, Peralta C. Ischemic preconditioning increases the tolerance of fatty liver to hepatic ischemia-reperfusion injury in the rat. Am J Pathol 2002 161 : 587 601.
30. Yoshidome H, Kato A, Edwards MJ, Lentsch AB. Interleukin-10 suppresses hepatic ischemia/reperfusion injury in mice: Implications of a central role for nuclear factor kappaB. Hepatology 1999 30 : 203 208.
31. Tashiro H, Shinozaki K, Yahata H et al. Prolongation of liver allograft survival after interleukin-10 gene transduction 24-48 hours before donation. Transplantation 2000 70 : 336 339.
32. McTaggart RA, Terrault NA, Vardanian AJ, Bostrom A, Feng S. Hepatitis C etiology of liver disease is strongly associated with early acute rejection following liver transplantation. Liver Transpl 2004 10 : 975 985.
33. Glanemann M, Langrehr JM, Stange BJ et al. Clinical implications of hepatic preservation injury after adult liver transplantation. Am J Transplant 2003 3 : 1003 1009.
34. Berenguer M, Prieto M, San Juan F et al. Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients. Hepatology 2002 36 : 202 210.